glp 1 for alzheimer's Frontiers Details of failed studies cast

Despite short serum half-life, daily dosing produces robust, sustained tissue-repair effects in rodent models

Learn more about what an MDL is

Thereby, BPC 157 effects on counteraction of ketamine-cognition dysfunction, social withdrawal, and anhedonia, and exerted additional anxiolytic effect, in addition to well-suited models (i.e., cognitive dysfunction (novel object recognition test)) [207,208,209], social withdrawal [210,211], anhedonia (sucrose test) [212,213], anxiogenic effect (open field test) [214,215], can have a particular background

That's the question

It can slow disease progression

The best time is whenever you can take it consistently